Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
For a comprehensive list, see our complete guide to supplements to take with GLP-1 and supplements for tirzepatide users
The current Retatrutide availability is strictly limited to participants in authorized clinical trials, as it has not yet received regulatory approval from the FDA
Some people might have a higher risk due to genetic or immune system factors
Refer to the concentration tables below to choose how much water to add
Patients may experience increased salivation (sialorrhea) as a prodrome to nausea or vomiting, or conversely, may notice reduced appetite affecting their oral intake patterns
A survey released by KFF this week found that one in eight adults said theyve taken a GLP-1 drug, which are currently targeted for patients with diabetes, obesity and heart disease, and over 80% have at least heard of them
